Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kelly A. Sillence"'
Autor:
Sharon J. Brown, Rachel A. Kline, Silvia A. Synowsky, Sally L. Shirran, Ian Holt, Kelly A. Sillence, Peter Claus, Brunhilde Wirth, Thomas M. Wishart, Heidi R. Fuller
Publikováno v:
Cells, Vol 11, Iss 17, p 2624 (2022)
Most research to characterise the molecular consequences of spinal muscular atrophy (SMA) has focused on SMA I. Here, proteomic profiling of skin fibroblasts from severe (SMA I), intermediate (SMA II), and mild (SMA III) patients, alongside age-match
Externí odkaz:
https://doaj.org/article/3cd4a33860b94e2dbe9ab7ac17ec3748
Publikováno v:
Diagnostics, Vol 3, Iss 2, Pp 291-314 (2013)
Down’s syndrome (DS) is the most common genetic cause of developmental delay with an incidence of 1 in 800 live births, and is the predominant reason why women choose to undergo invasive prenatal diagnosis. However, as invasive tests are associated
Externí odkaz:
https://doaj.org/article/d704582c66ef4c4da9c0a0c4d96700bf
Autor:
Tracey E. Madgett, Amr J Halawani, Kirsty A Clarke, Kelly A. Sillence, Wajnat A Tounsi, Michele Kiernan, Neil D. Avent
Publikováno v:
Clinical Chemistry. 63:1388-1397
BACKGROUND Paternal zygosity testing is used for determining homo- or hemizygosity of RHD in pregnancies that are at a risk of hemolytic disease of the fetus and newborn. At present, this is achieved by using real-time PCR or the Rhesus box PCR, whic
Publikováno v:
Diagnostics
Diagnostics, Vol 3, Iss 2, Pp 291-314 (2013)
Diagnostics, Vol 3, Iss 2, Pp 291-314 (2013)
Down’s syndrome (DS) is the most common genetic cause of developmental delay with an incidence of 1 in 800 live births, and is the predominant reason why women choose to undergo invasive prenatal diagnosis. However, as invasive tests are associated
Autor:
T Miran, Kelly A. Sillence, N Kaushik, Alastair J.S. Webb, Tracey E. Madgett, Neil D. Avent, Michele Kiernan
Publikováno v:
Balkan Journal of Medical Genetics, Vol 15, Iss Supplement, Pp 17-26 (2012)
Balkan Journal of Medical Genetics : BJMG
Balkan Journal of Medical Genetics : BJMG
Current invasive procedures [amniocentesis and chorionic villus sampling (CVS)] pose a risk to mother and fetus and such diagnostic procedures are available only to high risk pregnancies limiting aneuploidy detection rate. This review seeks to highli
Autor:
Kelly A, Sillence, Amr J, Halawani, Wajnat A, Tounsi, Kirsty A, Clarke, Michele, Kiernan, Tracey E, Madgett, Neil D, Avent
Publikováno v:
Clinical chemistry. 63(8)
Paternal zygosity testing is used for determining homo- or hemizygosity ofDNA samples extracted from 53 blood donors were analyzed using 2 multiplex reactions forThe results showed clear and reliable determination ofDigital PCR provides a highly accu
Autor:
Neil D. Avent, Michele Kiernan, C. Ross Welch, Kelly A. Sillence, Hannah P. Thompson, Llinos A. Roberts, Tracey E. Madgett, Heidi J. Hollands
Publikováno v:
Clinical chemistry. 61(11)
BACKGROUND Noninvasive genotyping of fetal RHD (Rh blood group, D antigen) can prevent the unnecessary administration of prophylactic anti-D to women carrying RHD-negative fetuses. We evaluated laboratory methods for such genotyping. METHODS Blood sa